HNSCC:1 (MTSS1)

Maurice Klein1, Kai Wermker2, Ashkan Rashad1

  • 1Department of Oral & Maxillofacial Surgery, School of Medicine, University Hospital RWTH Aachen, Aachen, Germany.

概括

转移抑制蛋白1 (MTSS1) 强度,而不是表达,是头支状细胞癌 (HNSCC) 的关键预后标志物. 较高的MTSS1强度与瘤的攻击性,转移和患者存活率的降低相关.